Fortress Biotech, Inc. (FBIO)

Fortress Biotech Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	59.29	56.68	64.99	73.07	68.79	45.6
Other Revenue	3.01	1	19.52	2.67	-	-
Revenue	62.3	57.68	84.51	75.74	68.79	45.6
Revenue Growth (YoY)	-23.56%	-31.76%	11.58%	10.11%	50.86%	24.49%
Cost of Revenue	42.37	77.76	128.96	165.65	160.95	78.7
Gross Profit	19.93	-20.09	-44.45	-89.91	-92.16	-33.1
Selling, General & Admin	104.84	84.04	87.84	113.66	86.84	61.17
Amortization of Goodwill & Intangibles	4.17	3.42	3.77	-	-	-
Other Operating Expenses	-4.55	-4.55	-	-	-	-
Operating Expenses	104.46	82.91	91.61	113.66	86.84	61.17
Operating Income	-84.53	-103	-136.06	-203.56	-179	-94.27
Interest Expense	-14.24	-13.53	-15.32	-13.64	-15.31	-15.33
Interest & Investment Income	2.37	2.68	3	1.4	0.65	1.52
Other Non Operating Income (Expenses)	32.2	0.68	1.02	2.34	-0.45	-1.19
EBT Excluding Unusual Items	-64.2	-113.16	-147.35	-213.46	-194.11	-109.27
Gain (Loss) on Sale of Investments	-15.08	-	-	-	39.29	6.42
Gain (Loss) on Sale of Assets	27.13	-	-	-	-	-
Asset Writedown	-4.74	-7.38	-6.29	-	-	-
Other Unusual Items	3.58	-	-	-	-9.54	-
Pretax Income	-53.3	-120.54	-153.63	-213.46	-164.35	-102.85
Income Tax Expense	0.53	0.31	0.52	0.45	0.47	0.14
Earnings From Continuing Operations	-53.83	-120.86	-154.15	-213.91	-164.83	-102.99
Net Income to Company	-53.83	-120.86	-154.15	-213.91	-164.83	-102.99
Minority Interest in Earnings	57.82	74.86	93.52	127.34	100.12	56.46
Net Income	3.99	-46	-60.64	-86.58	-64.7	-46.53
Preferred Dividends & Other Adjustments	9.32	9.89	8.03	8.03	-	-
Net Income to Common	-5.34	-55.89	-68.67	-94.61	-64.7	-46.53
Shares Outstanding (Basic)	27	21	8	6	5	5
Shares Outstanding (Diluted)	27	21	8	6	5	5
Shares Change (YoY)	57.99%	156.25%	36.89%	8.78%	13.46%	31.61%
EPS (Basic)	-0.20	-2.69	-8.47	-15.97	-11.88	-9.69
EPS (Diluted)	-0.20	-2.69	-8.47	-15.97	-11.88	-9.69
Free Cash Flow	-66.14	-80.19	-128.29	-182.12	-121.11	-85.61
Free Cash Flow Per Share	-2.47	-3.86	-15.82	-30.74	-22.23	-17.83
Gross Margin	31.99%	-34.82%	-52.60%	-118.70%	-133.97%	-72.60%
Operating Margin	-135.68%	-178.58%	-160.99%	-268.76%	-260.21%	-206.74%
Profit Margin	-8.57%	-96.91%	-81.25%	-124.91%	-94.06%	-102.03%
Free Cash Flow Margin	-106.16%	-139.04%	-151.80%	-240.44%	-176.05%	-187.74%
EBITDA	-79.9	-98.53	-130.06	-196.18	-173.9	-90.57
EBITDA Margin	-128.25%	-170.84%	-153.89%	-259.00%	-252.79%	-198.62%
D&A For EBITDA	4.63	4.46	6	7.39	5.1	3.7
EBIT	-84.53	-103	-136.06	-203.56	-179	-94.27
EBIT Margin	-135.68%	-178.58%	-160.99%	-268.76%	-260.21%	-206.74%
Revenue as Reported	62.3	57.68	84.51	75.74	68.79	45.6

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q